81 related articles for article (PubMed ID: 15304350)
1. Repression of the c-fms gene in fibroblast cells by c-Myc-MM-1-TIF1beta complex.
Satou A; Hagio Y; Taira T; Iguchi-Ariga SM; Ariga H
FEBS Lett; 2004 Aug; 572(1-3):211-5. PubMed ID: 15304350
[TBL] [Abstract][Full Text] [Related]
2. Distinct localizations and repression activities of MM-1 isoforms toward c-Myc.
Hagio Y; Kimura Y; Taira T; Fujioka Y; Iguchi-Ariga SM; Ariga H
J Cell Biochem; 2006 Jan; 97(1):145-55. PubMed ID: 16173081
[TBL] [Abstract][Full Text] [Related]
3. c-MYC repression of promoter activity through core promoter elements.
Lucas JM; Wilkie NM; Lang JC
Biochem Biophys Res Commun; 1993 Aug; 194(3):1446-52. PubMed ID: 8352803
[TBL] [Abstract][Full Text] [Related]
4. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
Marcotte R; Chen JM; Huard S; Wang E
J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of the Wnt signal by MM-1 through inhibiting expression of the wnt4 gene.
Yoshida T; Kitaura H; Hagio Y; Sato T; Iguchi-Ariga SM; Ariga H
Exp Cell Res; 2008 Apr; 314(6):1217-28. PubMed ID: 18281035
[TBL] [Abstract][Full Text] [Related]
6. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
7. Expression of the TAF4b gene is induced by MYC through a non-canonical, but not canonical, E-box which contributes to its specific response to MYC.
Teye K; Okamoto K; Tanaka Y; Umata T; Ohnuma M; Moroi M; Kimura H; Tsuneoka M
Int J Oncol; 2008 Dec; 33(6):1271-80. PubMed ID: 19020761
[TBL] [Abstract][Full Text] [Related]
8. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.
Allen RR; Qi L; Higgins PJ
J Cell Physiol; 2005 Apr; 203(1):156-65. PubMed ID: 15372465
[TBL] [Abstract][Full Text] [Related]
9. Promoter-binding and repression of PDGFRB by c-Myc are separable activities.
Mao DY; Barsyte-Lovejoy D; Ho CS; Watson JD; Stojanova A; Penn LZ
Nucleic Acids Res; 2004; 32(11):3462-8. PubMed ID: 15226411
[TBL] [Abstract][Full Text] [Related]
10. Induction of cell death in murine fibroblasts by a c-myc promoter binding protein.
Ray RB
Cell Growth Differ; 1995 Sep; 6(9):1089-96. PubMed ID: 8519685
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
Li H; Wu X
Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
[TBL] [Abstract][Full Text] [Related]
12. Functional divergence of duplicated c-myc genes in a tetraploid fish, the common carp (Cyprinus carpio).
Futami K; Zhang H; Okamoto N
Gene; 2005 Dec; 363():61-6. PubMed ID: 16242865
[TBL] [Abstract][Full Text] [Related]
13. Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from Ganoderma tsugae in A549 human lung adenocarcinoma cell line.
Liao CH; Hsiao YM; Hsu CP; Lin MY; Wang JC; Huang YL; Ko JL
Mol Carcinog; 2006 Apr; 45(4):220-9. PubMed ID: 16402390
[TBL] [Abstract][Full Text] [Related]
14. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells.
de Nigris F; Botti C; Rossiello R; Crimi E; Sica V; Napoli C
Oncogene; 2007 Jan; 26(3):382-94. PubMed ID: 16878156
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells.
Yang J; Deng X; Deng L; Gu H; Fan W; Cao Y
J Exp Clin Cancer Res; 2004 Sep; 23(3):495-506. PubMed ID: 15595642
[TBL] [Abstract][Full Text] [Related]
16. Dominant negative mutants of Myc inhibit cooperation of both Myc and adenovirus serotype-5 E1a with Ras.
MacGregor D; Li LH; Ziff EB
J Cell Physiol; 1996 Apr; 167(1):95-105. PubMed ID: 8698846
[TBL] [Abstract][Full Text] [Related]
17. Sp3 repression of polymorphic human NRH:quinone oxidoreductase 2 gene promoter.
Wang W; Jaiswal AK
Free Radic Biol Med; 2004 Oct; 37(8):1231-43. PubMed ID: 15451063
[TBL] [Abstract][Full Text] [Related]
18. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
Cosgrave N; Hill AD; Young LS
J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the oncoprotein c-Myc in viral telomerase RNA gene regulation during Marek's disease virus-induced lymphomagenesis.
Shkreli M; Dambrine G; Soubieux D; Kut E; Rasschaert D
J Virol; 2007 May; 81(9):4848-57. PubMed ID: 17314164
[TBL] [Abstract][Full Text] [Related]
20. c-Myc inhibits CD11a and CD11c leukocyte integrin promoters.
López-Rodríguez C; Delgado MD; Puig-Kröger A; Nueda A; Muñoz E; León J; Bernabéu C; Corbi AL
Eur J Immunol; 2000 Sep; 30(9):2465-71. PubMed ID: 11009078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
